Xgene Pharmaceutical Funding: $60M Raised, Series C (2021)
Xgene Pharmaceutical is based in Taiwan. It has raised $60M in total funding. Latest round: Series C.
Xgene Pharmaceutical funding overview
Xgene Pharmaceutical is based in Taiwan. Xgene Pharmaceutical has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2021. The round record for Xgene Pharmaceutical runs through 2021; nothing later has been disclosed.
Xgene Pharmaceutical at a glance
Total raised
$60M
Latest round
Series C
Latest round date
November 2021
Headquarters
Taiwan
Frequently asked about Xgene Pharmaceutical funding
How much has Xgene Pharmaceutical raised?
Xgene Pharmaceutical has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Xgene Pharmaceutical?
No investors are named on the public record for Xgene Pharmaceutical yet.
What was the latest Xgene Pharmaceutical funding round?
The most recent disclosed round is a Series C, announced in November 2021.
Where is Xgene Pharmaceutical based?
Xgene Pharmaceutical is based in Taiwan.
When did Xgene Pharmaceutical last raise?
The last disclosed Xgene Pharmaceutical round closed in November 2021 at Series C.
We update the Xgene Pharmaceutical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Taiwan and their backers are listed below.
